Celcuity LLC IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Celcuity LLC | CELC - NASDAQ |
$8.00-$10.00 | $9.50 | $12.35 | 2.4 million | 9/20/2017 |
| Craig Hallum Capital Group | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2017-08-23 Terms Added 2017-09-07 | ||||||
Celcuity LLC Quote & Chart - Click for current quote - CELC
IPO Boutique aggregates information on public companies and private companies, such as "CELC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Celcuity LLC (adapted from Celcuity LLC prospectus):
They are a cellular analysis company that is discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a cellular analysis company that is discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "CELC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.